147 related articles for article (PubMed ID: 38614983)
21. Prognostic role of radiological splenic vessel involvement in patients with resectable pancreatic ductal adenocarcinoma of the body and tail: A retrospective analysis based on a large population.
Tan Q; Chen C; Wang Z; Zhang H; Liu X; Ke N
Eur J Radiol; 2023 Aug; 165():110952. PubMed ID: 37421772
[TBL] [Abstract][Full Text] [Related]
22. High-resolution pancreatic computed tomography for assessing pancreatic ductal adenocarcinoma resectability: a multicenter prospective study.
Lee DH; Ha HI; Jang JY; Lee JW; Choi JY; Bang S; Lee CH; Kim WB; Lee SS; Kim SC; Kang BK; Lee JM
Eur Radiol; 2023 Sep; 33(9):5965-5975. PubMed ID: 36988715
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma.
Kaufmann B; Hartmann D; D'Haese JG; Stupakov P; Radenkovic D; Gloor B; Friess H
Dig Surg; 2019; 36(6):455-461. PubMed ID: 30408790
[TBL] [Abstract][Full Text] [Related]
24. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
[TBL] [Abstract][Full Text] [Related]
25. Para-aortic lymph nodes and ductal adenocarcinoma of the pancreas: Distant neighbors?
Safi SA; Rehders A; Haeberle L; Fung S; Lehwald N; Esposito I; Ziayee F; Krieg A; Knoefel WT; Fluegen G
Surgery; 2021 Dec; 170(6):1807-1814. PubMed ID: 34392977
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Significance of Lymph Node Metastasis and Micrometastasis Along the Left Side of Superior Mesenteric Artery in Pancreatic Head Cancer.
Okada K; Murakami Y; Kondo N; Uemura K; Nakagawa N; Seo S; Takahashi S; Sueda T
J Gastrointest Surg; 2019 Oct; 23(10):2100-2109. PubMed ID: 31410820
[TBL] [Abstract][Full Text] [Related]
27. Reevaluation of regional lymph nodes in patients with pancreatic ductal adenocarcinoma in the pancreatic body and tail.
Matsui Y; Hashimoto D; Satoi S; Yamamoto T; Yamaki S; Ishida M; Hirooka S; Ikeura T; Sekimoto M
Ann Gastroenterol Surg; 2023 Jan; 7(1):147-156. PubMed ID: 36643361
[TBL] [Abstract][Full Text] [Related]
28. Lymph Node Metastatic Patterns and Survival Predictors Based on Tumor Size in Pancreatic Ductal Adenocarcinoma.
Pu N; Chen Q; Gan W; Shen Y; Gao S; Habib JR; Yin H; Zhang J; Kinny-Köster B; Cui M; Li J; Dong Y; Nagai M; Liu L; Yu J; Wu W; Lou W
Adv Ther; 2021 Aug; 38(8):4258-4270. PubMed ID: 34176089
[TBL] [Abstract][Full Text] [Related]
29. Analysis of paraaortic lymph node involvement in pancreatic carcinoma: a significant indication for surgery?
Kayahara M; Nagakawa T; Ohta T; Kitagawa H; Ueno K; Tajima H; Elnemr A; Miwa K
Cancer; 1999 Feb; 85(3):583-90. PubMed ID: 10091731
[TBL] [Abstract][Full Text] [Related]
30. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS).
Tol JA; Gouma DJ; Bassi C; Dervenis C; Montorsi M; Adham M; Andrén-Sandberg A; Asbun HJ; Bockhorn M; Büchler MW; Conlon KC; Fernández-Cruz L; Fingerhut A; Friess H; Hartwig W; Izbicki JR; Lillemoe KD; Milicevic MN; Neoptolemos JP; Shrikhande SV; Vollmer CM; Yeo CJ; Charnley RM;
Surgery; 2014 Sep; 156(3):591-600. PubMed ID: 25061003
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease.
Williams JL; Nguyen AH; Rochefort M; Muthusamy VR; Wainberg ZA; Dawson DW; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
J Surg Oncol; 2015 Sep; 112(4):396-402. PubMed ID: 26303811
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic body and tail cancer and favorable metastatic lymph node behavior on the left edge of the aorta.
Tanaka K; Nakamura T; Asano T; Nakanishi Y; Noji T; Tsuchikawa T; Okamura K; Shichinohe T; Hirano S
Pancreatology; 2020 Oct; 20(7):1451-1457. PubMed ID: 32868183
[TBL] [Abstract][Full Text] [Related]
33. Should a standard lymphadenectomy include the No. 9 lymph nodes for body and tail pancreatic ductal adenocarcinoma?
Zhou Y; Lin J; Wang W; Chen H; Deng X; Peng C; Cheng D; Shen B
Pancreatology; 2019 Apr; 19(3):414-418. PubMed ID: 30902419
[TBL] [Abstract][Full Text] [Related]
34. K-ras point mutation in the nerve plexuses around the superior mesenteric artery in resectable adenocarcinoma of the pancreatic head: distribution pattern and related factors.
Ohigashi H; Ishikawa O; Sasaki Y; Yamada T; Furukawa H; Imaoka S; Kasugai T; Ishiguro S; Ueda K; Miyoshi Y; Nakamura Y
Arch Surg; 2000 Dec; 135(12):1450-5. PubMed ID: 11115351
[TBL] [Abstract][Full Text] [Related]
35. Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance.
Wang L; Xiong L; Wu Z; Miao X; Liu Z; Li D; Zou Q; Yang Z
World J Surg Oncol; 2018 Jan; 16(1):11. PubMed ID: 29347944
[TBL] [Abstract][Full Text] [Related]
36. Are Lymph Node Metastases Associated With Survival in Black Patients With Pancreatic Cancer?
Fang HA; Irfan A; Vickers SM; Gbolahan O; Williams GR; Outlaw D; Wang TN; Dudeja V; Rose JB; Reddy S
J Surg Res; 2023 Apr; 284():143-150. PubMed ID: 36571869
[TBL] [Abstract][Full Text] [Related]
37. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
[TBL] [Abstract][Full Text] [Related]
38. Patient outcome according to the 2017 international consensus on the definition of borderline resectable pancreatic ductal adenocarcinoma.
Medrano J; Garnier J; Ewald J; Marchese U; Gilabert M; Launay S; Poizat F; Giovannini M; Delpero JR; Turrini O
Pancreatology; 2020 Mar; 20(2):223-228. PubMed ID: 31839458
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail.
Kitamura K; Esaki M; Sone M; Sugawara S; Hiraoka N; Nara S; Ban D; Takamoto T; Mizui T; Shimada K
Ann Surg Oncol; 2022 Oct; 29(11):7047-7058. PubMed ID: 35691957
[TBL] [Abstract][Full Text] [Related]
40. Predicting Surgical Margins in Patients With Borderline Resectable and Locally Advanced Pancreatic Cancer Undergoing Resection.
Ren W; Xourafas D; Ashley SW; Clancy TE
Am Surg; 2022 Dec; 88(12):2899-2906. PubMed ID: 33861651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
